Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice

References

• Scarpini E, Scheltens P, Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2003;2:539–547.
   PubMed Web of Science ®Google Scholar
• Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med 1971;50:475–492.
   PubMed Web of Science ®Google Scholar
• Ellis JM. Cholinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc 2005;105:145–158.
   PubMedGoogle Scholar
• Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. JAMA 1992;268: 2523–2529.
   PubMed Web of Science ®Google Scholar
• Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA 1994;271:985–991.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Farlow MR, Grieg NH, Sambamurti K. Current drug targets for Alzheimer's disease treatment. Drug Dev Res 2002;56:267–281.
   Web of Science ®Google Scholar
• Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study group. Neurology 1998;50:136–145.
   PubMed Web of Science ®Google Scholar
• Zhao B. Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease. Neurochem Res 2009;34: 630–638.
   PubMed Web of Science ®Google Scholar
• Hatip-Al-Khatib I, Egashira N, Mishima K, Iwasaki K, Iwasaki K, Kurauchi K, Inui K, Ikeda T, Fujiwara M. Determination of the effectiveness of components of the herbal medicine Toki-Shakuyaku-San and fractions of Angelica acutiloba in improving the scopolamine-induced impairment of rat's spatial cognition in eight-armed radial maze test. J Pharmacol Sci 2004;96:33–41.
   PubMedGoogle Scholar
• Kang SY, Lee KY, Park MJ, Kim YC, Markelonis GJ, Oh TH, Kim YC. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol Learn Mem 2003;79:11–18.
   PubMed Web of Science ®Google Scholar
• Kang SY, Lee KY, Koo KA, Yoon JS, Lim SW, Kim YC, Sung SH. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice. Life Sci 2005;76:1691–1705.
   PubMed Web of Science ®Google Scholar
• Houghton PJ, Agbedahunsi JM, Adegbulugbe A. Choline esterase inhibitory properties of alkaloids from two Nigerian Crinum species. Phytochemistry 2004;65:2893–2896.
   PubMed Web of Science ®Google Scholar
• Yamada N, Hattori A, Hayashi T, Nishikawa T, Fukuda H, Fujino T. Improvement of scopolamine-induced memory impairment by Z-ajoene in the water maze in mice. Pharmacol Biochem Behav 2004;78:787–791.
   PubMed Web of Science ®Google Scholar
• Yan JJ, Kim DH, Moon YS, Jung JS, Ahn EM, Baek NI, Song DK. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:25–30.
   PubMed Web of Science ®Google Scholar
• Yu MS, Leung SK, Lai SW, Che CM, Zee SY, So KF, Yuen WH, Chang RC. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp Gerontol 2005;40:716–727.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Zhu X, Liu Q, Honda K, Siedlak SL, Harris PL, Smith MA, Perry G. Compensatory responses induced by oxidative stress in Alzheimer disease. Biol Res 2006;39: 7–13.
   PubMedGoogle Scholar
• El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary Eel D. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 2003;76:525–533.
   PubMed Web of Science ®Google Scholar
• Chiu PY, Leung HY, Poon MK, Ko KM. Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats. Biogerontology 2006;7: 199–210.
   PubMedGoogle Scholar
• Mak DH, Ip SP, Li PC, Poon MK, Ko KM. Effects of Schisandrin B and alpha-tocopherol on lipid peroxidation, in vitro and in vivo. Mol Cell Biochem 1996;20:161–165.
   Google Scholar
• Zhu YP. Chinese materia medica chemistry, pharmacology and applications. The Netherlands: Harwood Academic Publishers; 1998. 653–657.
   Google Scholar
• Liu GT. Pharmacological actions and clinical use of fructus schizandrae. Chin Med J 1989;102:740–749.
   PubMed Web of Science ®Google Scholar
• Ko KM, Mak D. Schisdandrin B and other dibenzocyclooctadiene lignans. New York: Marcel Dekker; 2004.
   Google Scholar
• Xuejiang W, Magara T, Konishi T. Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats. Free Radic Res 1999;31: 449–455.
   PubMed Web of Science ®Google Scholar
• Nishida H, Kushida M, Nakajima Y, Ogawa Y, Tatewaki N, Sato S, Konishi T. Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction. J Pharmacol Sci 2007;104:73–81.
   PubMed Web of Science ®Google Scholar
• Kim DH, Hung TM, Bae KH, Jung JW, Lee S, Yoon BH, Cheong JH, Ko KH, Ryu JH. Gomisin A improves scopolamine-induced memory impairment in mice. Eur J Pharmacol 2006;542:129–135.
   PubMed Web of Science ®Google Scholar
• Egashira N, Kurauchi K, Iwasaki K, Mishima K, Orito K, Oishi R, Fujiwara M. Schizandrin reverses memory impairment in rats. Phytother Res 2008;22:49–52.
   PubMedGoogle Scholar
• Song JX, Lin X, Wong RN, Sze SC, Tong Y, Shaw PC, Zhang YB. Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells. Phytother Res 2011;25:435–443.
   PubMed Web of Science ®Google Scholar
• Ip SP, Poon MK, Wu SS, Che CT, Ng KH, Kong YC, Ko KM. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. Planta Med 1995;61:398–401.
   PubMed Web of Science ®Google Scholar
• Kim SR, Kang SY, Lee KY, Kim SH, Markelonis GJ, Oh TH, Kim YC. Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana. Brain Res Cogn Brain Res 2003;17:454–461.
   PubMedGoogle Scholar
• Das A, Dikshit M, Nath C. Role of molecular isoforms of acetylcholinesterase in learning and memory functions. Pharmacol Biochem Behav 2005;81:89–99.
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V, Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982;126:131–138.
   PubMed Web of Science ®Google Scholar
• Vincent D, Segonzac G, Vincent MC. [Colorimetric determination of acetylcholine by the Hestrin hydroxylamine reaction and its application in pharmacy.]. Ann Pharm Fr 1958;16: 179–185.
   PubMedGoogle Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–77.
   PubMed Web of Science ®Google Scholar
• Lankin VZ, Tikhaze AK, Kovalevskaia AL, Lemeshko VV, Vikhert AM. [Age-related changes in the glutathione- S-transferase and glutathione peroxidase activity of rat liver cytosol]. Dokl Akad Nauk SSSR 1981;261:1467–1470.
   PubMedGoogle Scholar
• Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD. Spontaneousintracerebral hemorrhage during acute and chronic hypertension in mice. J Cereb Blood Flow Metab 2010;30:56–69.
   PubMed Web of Science ®Google Scholar
• Saito K, Honda S, Tobe A, Yanagiya I. Effects of bifemelane hydrochloride (MCI-2016) on acetylcholine level reduced by scopolamine, hypoxia and ischemia in the rats and mongolian gerbils. Jpn J Pharmacol 1985;38:375–380.
   PubMedGoogle Scholar
• Guo LY, Hung TM, Bae KH, Shin EM, Zhou HY, Hong YN, Kang SS, Kim HP, Kim YS. Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. Eur J Pharmacol 2008;591:293–299.
   PubMed Web of Science ®Google Scholar
• Bejar C, Wang RH, Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 1999;383:231–240.
   PubMed Web of Science ®Google Scholar
• Jones RW, Wesnes KA, Kirby J. Effects of NMDA modulation in scopolamine dementia. Ann N Y Acad Sci 1991;640: 241–244.
   PubMed Web of Science ®Google Scholar
• LeDoux JE. Emotional memory systems in the brain. Behav Brain Res 1993;58:69–79.
   PubMed Web of Science ®Google Scholar
• Upchurch M, Wehner JM. Effects of chronic diisopropylfluorophosphate treatment on spatial learning in mice. Pharmacol Biochem Behav 1987;27:143–151.
   PubMed Web of Science ®Google Scholar
• Giacobini E. Cholinesterases: new roles in brain function and in Alzheimer's disease. Neurochem Res 2003;28:515–522.
   PubMed Web of Science ®Google Scholar
• Adamson ED. Acetylcholinesterase in mouse brain, erythrocytes and muscle. J Neurochem 1977;28:605–615.
   PubMedGoogle Scholar
• Massoulie J, Pezzementi L, Bon S, Krejci E, Vallette FM. Molecular and cellular biology of cholinesterases. Prog Neurobiol 1993;41:31–91.
   PubMed Web of Science ®Google Scholar
• Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010;59:290–294.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki Y, Melamed E, Offen D. Antioxidant treatment in Alzheimer's disease: current state. J Mol Neurosci 2003;21:1–11.
   PubMed Web of Science ®Google Scholar
• Pong K. Oxidative stress in neurodegenerative disease: therapeutic implications for superoxide dismutase mimetics. Expert Opinion on Biol Therapy 2003;3:127–139.
   PubMed Web of Science ®Google Scholar